(HealthDay)—Obizur (antihemophilic factor recombinant) has been approved to treat a rare, non-inherited form of hemophilia in adults.
Oct 24, 2014
not rated yet | 0
The Roman-British population from c. 200-400 AD appears to have had far less gum disease than we have today, according to a study of skulls at the Natural History Museum led by a King's College London periodontist. The surprise ...
Oct 23, 2014
5 / 5 (1) | 0